Sabotaging the protein factory to overcome glioma stem cell resistance
Neuro-Oncology · 2023
DOI: 10.1093/neuonc/noad090 ↗Kurz gefasst
Editorial in der Zeitschrift Neuro-Oncology, 2023. Verfasst von Santiago Haase und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Glioblastoma, Glioma, Brain Neoplasms. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.
- Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
- Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA.
- Department of Biomedical Engineering, University of Michigan Medical School, Ann Arbor, Michigan, USA.
ORCID-Profile: Santiago Haase, Pedro R Lowenstein
Förderung
- NINDS NIH HHS
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke
- Rogel Cancer Center Scholar Award
- National Cancer Institute
- Pediatric Brain Tumor Foundation
Zitieren
APA
Haase, S., Lowenstein, P. R., & Castro, M. G. (2023). Sabotaging the protein factory to overcome glioma stem cell resistance. Neuro-Oncology. https://doi.org/10.1093/neuonc/noad090
Vancouver
Haase S, Lowenstein PR, Castro MG. Sabotaging the protein factory to overcome glioma stem cell resistance. Neuro-Oncology. 2023. doi:10.1093/neuonc/noad090
BibTeX
@article{Haase2023,
author = {Haase, Santiago and Lowenstein, Pedro R and Castro, Maria G},
title = {Sabotaging the protein factory to overcome glioma stem cell resistance},
journal = {Neuro-Oncology},
year = {2023},
doi = {10.1093/neuonc/noad090}
}
EUVIMED